Comprehensive Analysis of Hypermutation in Human CancerBrittany Campbell, Melyssa Aronson, Tanner M. Johanns et al.|Cell|2017Cited by 795
Longitudinal molecular trajectories of diffuse glioma in adultsFloris P Barthel, Kerrie L. McDonald, Kevin C. Johnson et al.|Nature|2019Cited by 594
Antibody targeting of E3 ubiquitin ligases for receptor degradationHadir Marei, Felipe de Sousa e Melo, Wen‐Ting K. Tsai et al.|Nature|2022Cited by 254
Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYCFredrik J. Swartling, William A. Weiss, Vasil Savov et al.|Cancer Cell|2012Cited by 211
MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrenceRadhika Mathur, J Costello, Yalan Zhang et al.|Neuro-Oncology|2020Cited by 96